General Information of Drug (ID: DM2UZL9)

Drug Name
Bufexamac Drug Info
Synonyms
bufexamac; 2438-72-4; Bufexamic acid; 2-(4-Butoxyphenyl)-N-hydroxyacetamide; Parfenac; Parfenal; Feximac; Mofenar; Malipuran; Droxaryl; Bufexamacum; Flogicid; Bufexamaco; Paraderm; Norfemac; Anderm; 4-Butoxy-N-hydroxybenzeneacetamide; p-Butoxyphenylacetohydroxamic acid; 4-Butoxyphenylacetohydroxamic acid; Flogocid N plastigel; Acide p-butoxyphenylacethydroxamique; 2-(p-Butoxyphenyl)-acetohydroxamic acid; Bufessamac [DCIT]; Bufexamacum [INN-Latin]; Bufexamaco [INN-Spanish]; CP 1044 J3; UNII-4T3C38J78L; Benzeneacetamide, 4-butoxy-N-hyd
Cross-matching ID
PubChem CID
2466
ChEBI ID
CHEMBL94394
CAS Number
CAS 2438-72-4
TTD Drug ID
D02HXS

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Galactose metabolism 1.86 3.63e-2 26/31 (83.87%) PFKP;AKR1B1;AKR1B10;...
Lysosome 1.84 3.94e-2 115/128 (89.84%) CTSH;LAPTM5;PSAP;...
Glycolysis / Gluconeogenesis 1.83 3.15e-2 56/67 (83.58%) PKM;ADH5;PFKP;...
Cell adhesion molecules 1.82 3.23e-2 118/148 (79.73%) HLA-B;NRCAM;ALCAM;...
Terpenoid backbone biosynthesis 1.82 2.94e-2 18/22 (81.82%) ACAT2;IDI1;PCYOX1;...
Fructose and mannose metabolism 1.78 3.63e-2 30/33 (90.91%) PFKP;AKR1B1;PFKFB3;...
Propanoate metabolism 1.77 3.90e-2 30/34 (88.24%) ACAT2;SUCLG2;HIBCH;...
Shigellosis 1.76 3.88e-2 180/246 (73.17%) CRK;TLR4;PFN2;...
HIF-1 signaling pathway 1.74 4.07e-2 105/109 (96.33%) TLR4;PFKP;ERBB2;...
Bacterial invasion of epithelial cells 1.72 4.54e-2 59/77 (76.62%) CRK;CDH1;ITGB1;...
Mismatch repair -1.70 3.48e-2 22/23 (95.65%) EXO1;MLH1;RFC5;...
Mineral absorption -1.74 2.71e-2 48/60 (80%) FTH1;MT2A;TF;...
Base excision repair -1.87 7.47e-3 29/33 (87.88%) PARP1;MUTYH;POLB;...
Taurine and hypotaurine metabolism -1.89 6.22e-3 8/11 (72.73%) GGT1;GAD2;CSAD;...
Fanconi anemia pathway -1.89 4.48e-3 36/54 (66.67%) ERCC1;FAN1;RPA3;...
Complement and coagulation cascades -1.92 3.73e-3 76/85 (89.41%) C1QB;F5;PLAUR;...
Staphylococcus aureus infection -1.97 2.49e-3 72/95 (75.79%) C1QB;FCGR2A;HLA-DMB;...
Cell cycle -2.09 0.00e+0 110/124 (88.71%) PKMYT1;TTK;MCM6;...
DNA replication -2.27 0.00e+0 34/36 (94.44%) POLD1;MCM6;DNA2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 24H